Monday, February 10, 2025
HomenewsSwedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates...

Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing – PR Newswire

RELATED ARTICLES

Leave a reply

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments